Drug Shortage Report for ACETAZOLAMIDE FOR INJECTION, USP
Report ID | 185664 |
Drug Identification Number | 02358328 |
Brand name | ACETAZOLAMIDE FOR INJECTION, USP |
Common or Proper name | ACETAZOLAMIDE FOR INJECTION, USP |
Company Name | STERIMAX INC |
Market Status | MARKETED |
Active Ingredient(s) | ACETAZOLAMIDE |
Strength(s) | 500MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1 vial |
ATC code | S01EC |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-02-28 |
Estimated end date | 2023-03-06 |
Actual end date | 2023-03-02 |
Shortage status | Resolved |
Updated date | 2023-03-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2023-03-03 | English | Compare |
v5 | 2023-03-02 | French | Compare |
v4 | 2023-03-02 | English | Compare |
v3 | 2023-03-01 | English | Compare |
v2 | 2023-02-28 | French | Compare |
v1 | 2023-02-28 | English | Compare |
Showing 1 to 6 of 6